Von Hippel-Lindau Disease: Clinical Considerations and the Use of Fluorescein-Potentiated Argon Laser Therapy for Treatment of Retinal Angiomas
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Seminars in Ophthalmology
- Vol. 7 (3) , 182-191
- https://doi.org/10.3109/08820539209065107
Abstract
(1992). Von Hippel-Lindau Disease: Clinical Considerations and the Use of Fluorescein-Potentiated Argon Laser Therapy for Treatment of Retinal Angiomas. Seminars in Ophthalmology: Vol. 7, No. 3, pp. 182-191. doi: 10.3109/08820539209065107Keywords
This publication has 23 references indexed in Scilit:
- Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.Proceedings of the National Academy of Sciences, 1991
- Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3Genomics, 1990
- Von Hippel-Lindau Disease Affecting 43 Members of a Single KindredMedicine, 1989
- von Hippel-Lindau DiseaseOphthalmology, 1984
- Treatment of Large von Hippel Tumors by Eye Wall ResectionOphthalmology, 1983
- Early Identification of Retinal Angiomas in a Large Kindred with Von Hippel-Lindau DiseaseAmerican Journal of Ophthalmology, 1980
- Perforating Diathermy Coagulation for Retinal AngiomasArchives of Ophthalmology (1950), 1976
- Von Hippel-Lindau DiseaseArchives of internal medicine (1960), 1976
- Argon Laser Treatment of von Hippel-Lindau Retinal AngiomasArchives of Ophthalmology (1950), 1974
- Argon Laser Treatment of von Hippel-Lindau Retinal AngiomasArchives of Ophthalmology (1950), 1974